Buspirone Hydrochloride Tablet
Product Images NDC 71335-1608

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71335-1608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg-one-third (10mg One Third)

FDA Label Image

10mg-two-thirds (10mg Two Thirds)

FDA Label Image

15mg-half (15mg Half)

FDA Label Image

15mg-splitting (15mg Splitting)

FDA Label Image

15mg-whole (15mg Whole)

FDA Label Image

20mg-two-thirds. (20mg Two Thirds)

FDA Label Image

30mg-splitting (30mg Splitting)

FDA Label Image

30mg-whole (30mg Whole)

FDA Label Image

5mg-one-third (5mg One Third)

FDA Label Image

7-5mg-half (7 5mg Half)

FDA Label Image
FDA Label Image

Chemical-structure-buspirone (Chemical Structure Buspirone)

FDA Label Image

Label (Lbl713351608)

Label (Lbl713351608)
This is a medication package for Buspirone HCI, a pink capsule drug used for treating anxiety disorders. It contains 60 capsules each with a strength of 30mg. The medication should be stored at a room temperature of 20°-25°C (68°-77°F) and kept out of reach of children. The manufacturer is Granules India Limited and the package code is NDC 7133516081 03333601523487.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.